<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical trials so far have not managed to show any benefit of this combination in the treatment. In a recently published article from a study in China, this combination has not shown any effective benefit. No significant differences in viral clearance or 28-day mortality rates were observed in 199 studied patients [
 <xref rid="R33" ref-type="bibr">33</xref>]. Adverse reactions should be kept in mind. The most frequently reported reactions in patients receiving lopinavir therapy are asthenia, diarrhea, and nausea. Elevated total bilirubin, hepatic enzyme levels, and triglycerides have also been reported [
 <xref rid="R34" ref-type="bibr">34</xref>].
</p>
